HighVista Strategies »

Lb Pharmaceuticals shares owned by HighVista Strategies

Quarter-by-quarter ownership of Lb Pharmaceuticals (LBRX) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Lb Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lb Pharmaceuticals held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lb Pharmaceuticals by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.1M 140k 22.26

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Structure Therapeutics Sponsored Ads (GPCR)
Cogent Biosciences (COGT)
Miragen Therapeutics (VRDN)
Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines (RVMD)
Praxis Precision Medicines I Com New (PRAX)
Nuvalent Inc-a (NUVL)
Cytokinetics Com New (CYTK)
Terns Pharmaceuticals (TERN)
Maze Therapeatics (MAZE)
Insmed Com Par $.01 (INSM)
Apogee Therapeutics (APGE)
Protagonist Therapeutics (PTGX)
Soleno Therapeutics (SLNO)

View all positions for HighVista Strategies

Top funds holding Lb Pharmaceuticals

Deep Track Capital
BlackRock
RA Capital Management
TCG Crossover Management
Commodore Capital
Logos Global Management
Vanguard Group
Balyasny Asset Management
Jennison Associates
Vivo Capital
Alyeska Investment Group
Nantahala Capital Management
Geode Capital Management
Citadel Advisors
Goldman Sachs Group

View all funds holding Lb Pharmaceuticals